Latest Technology Acquisitions News

Mesoblast delivered US$115 million in Ryoncil® revenue in its first full year post-FDA approval, while expanding clinical trials into adult indications and acquiring cutting-edge CAR technology to boost its cell therapy pipeline.

RooLife Group (ASX:RLG) is expanding its renewable energy footprint by acquiring a battery storage and microgrid business and raising $1.06 million in a placement to fund growth and project delivery.

Smart Parking (ASX:SPZ) has acquired American Parking, adding 54 sites across Oklahoma, Texas, and Arkansas and boosting its US portfolio to over 200 locations. The $12 million deal is expected to be earnings accretive and supports the rollout of SmartCloud technology.

Tasmea Limited is set to acquire JPS Group for up to A$75 million, securing a foothold in Australia’s growing LNG and energy infrastructure sectors with a Tier-1 client base and a unique tech-enabled isolation technology.

InVert Graphite (ASX:IVG) is set to acquire RapidGraphite Pty Ltd, gaining exclusive rights to Curtin University’s RapidPulseTM graphite processing technology that promises rapid, acid-free conversion of natural graphite to battery-grade quality. Backed by positive test results and a A$2.5 million capital raise, this move aims to vertically integrate InVert’s Morogoro graphite project with cutting-edge processing innovation.

Web Travel Group (ASX:WEB) reported a standout FY26, driven by its WebBeds B2B platform’s 20% TTV growth and 24% EBITDA increase, while redeeming $250 million convertible notes and releasing its inaugural climate-focused Sustainability Report.

Mesoblast Limited posted US$30.3 million in net revenues for Ryoncil® in Q3 2026, hitting key clinical milestones and securing new technology licenses that could boost its next-generation cell therapies.

TrivarX has made significant strides in preparing its Stabl-Im stable isotope imaging platform for Phase 1 clinical trials, backed by strengthened leadership and a solid cash reserve of $2.91 million.

GCM Corporation finalises exclusive rights to its Very High Density technology, launches its first commercial heat sink products, and expands global prototyping efforts targeting high-growth sectors including EV infrastructure and data centres.

TrivarX appoints Dr Danielle Meyrick as CEO to spearhead clinical trials and commercialisation of its novel stable isotope MRI brain cancer imaging platform, with Phase 1 studies on track for completion this year.

Nexion Group plans to delist from the ASX in April 2026 after disposing of its main assets, appointing Robert Minson as CEO to spearhead software acquisitions aimed at rebuilding the company for re-admission.

dorsaVi has confirmed that its proprietary RRAM memory technology and neuromorphic IP portfolio work seamlessly together, projecting a tenfold boost in performance for robotics and exoskeleton applications. This breakthrough lays the groundwork for smarter, faster, and more energy-efficient wearable and robotic devices operating at the ultra-edge.